1978-1980 Penn State University, University Park, PA -- June 1978-August 1979, June 1980-August 1980
1981 B.S. in Science with highest distinction, Penn State University
1979-1983 Jefferson Medical College, Philadelphia, PA
1983 M.D., Jefferson Medical College
1983-1986 Intern and Resident, Internal Medicine University of New Mexico Affiliated Hospitals Albuquerque, NM
1987 Chief Resident, Internal Medicine University of New Mexico Affiliated Hospitals Albuquerque, NM
1988-1991 Fellow, Division of Hematology/Oncology University of New Mexico Affiliated Hospitals Albuquerque, NM
1992-1995 Postdoctoral Biotechnology Fellow Laboratory of Human Carcinogenesis Curtis C. Harris, M.D., Chief National Cancer Institute, NIH, Bethesda, MD
- Gastrointestinal Cancers
- Cancer Genetics (Familial Cancer Program)
Dr. Greenblatt's research interests are in interpreting genetic variants in cancer susceptibility genes by using multiple lines of evidence (epidemiology, statistics, tumor pathology, evolution, structure, and function, computational algorithms). He has led projects that have integrated in vitro and in silico (computational) data to interpret genetic variation. Dr. Greenblatt’s current research activities involve interpretation of variants in the DNA mismatch Repair genes that are responsible for Lynch syndrome, the most common form of hereditary colorectal cancer.
1984 National Board of Medical Examiners
1986 American Board of Internal Medicine
1991, 2001, 2011 American Board of Internal MedicineSubspecialty in Medical Oncology
- Alliance for Clinical Trials in Oncology
- American Association of Cancer Research
- American Society of Human Genetics
- American Society of Clinical Oncology
- Collaborative Group of the Americas on Inherited Colorectal Cancer
- Human Genome Variation Society, Council Member
- Human Genome Organization (HUGO) Mutation Database Initiative
- Human Variome Project, Scientific Advisory Council
- IARC Working Group on Unclassified Genetic Variants
- International Society for Gastrointestinal Hereditary Tumors (InSiGHT)
- National Surgical Adjuvant Breast Program
- Vermont Medical Society
- Plon, SE, Eccles, DM, Easton, D, Foulkes, WD, Genuardi, M, Greenblatt, MS, Hogervorst, FBL, Hoogerbrugge, N, Spurdle, AB, Tavtigian, S, for the IARC Unclassified Genetic Variants Working Group (2008). Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results, Human Mutation, 29:1282-1291, 2008.
- Tavtigian SV, Greenblatt MS, Lesueur F, Byrnes GB, for the IARC Unclassified Genetic Variants Working Group. In silico analysis of missense substitutions using sequence-alignment based methods, Human Mutation, 29:1327-1336, 2008.
- Goldgar DE, Easton DF, Byrnes GB, Spurdle AB, Iversen ES, Greenblatt MS, for the IARC Unclassified Genetic Variants Working Group. Genetic evidence and integration of various data sources for classifying uncertain variants into a single model, Human Mutation, 29:1265-1272, 2008.
Cotton RGH, Auerbach AD, Axton M, Barash C, Berkovic S, Brookes AJ, Burn J, Cutting G, den Dunnen JT, Flicek P, Freimer N,Greenblatt MS, Howard HJ, Katz M, Macrae FA, Maglott D, et al. The Human Variome Project, Science, 322(5903):861-862, 2008.
- Miller PJ, Duraisamy S, Newell JA, Chan PA, Tie MM, Rogers AE, Ankuda CK, von Walstrom GM, Bond JP, Greenblatt MS, Classifying Variants of CDKN2A Using Computational and Laboratory Studies, Hum Mutat 2011 32:900-911. PMID: 21462282
For a complete list of Marc Greenblatt's publications, please visit Google Scholar.